Uric acid levels are inversely correlated with endothelial function in type 2 diabetic patients

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 7, 2016, Pages 14105-14113

  Altuntas, Atila ^a   Goksu, Sema Sezgin ^a   Kidir, Veysel ^a   Aydin, Zeynep Dilek ^a   Sezer, Mehmet Tugrul ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endothelial dysfunction; Hyperuricemia; Oxidative stress; Type 2 diabetes mellitus; Uric acid

Indexed keywords

CATALASE; CREATININE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTERY DILATATION; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR MORTALITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION; FEMALE; HUMAN; HYPERURICEMIA; MALE; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINALYSIS; VASODILATATION;

EID: 84985906270     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hartge M, Pharm B, Kintscher U, Unger T. Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am 2006; 35: 551-560.
2. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005; 109: 143-159.
3. Endemenn DH, Schriffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992.
4. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of uric acid to mortality and ischemic heart disease. The NHANES 1 epidemiologic Follow-up study. Am J Epidemiol 1995; 141: 637-644.
5. Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M, Bonora E. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009; 32: 1716-1720.
6. Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid related factors in 500 hospitalized subjects. Metabolism 1996; 45: 1557-1561.
7. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant Status and Lipid Peroxidation in Type II Diabetes Mellitus. Cell Biochem Func 2003; 21: 291-296.
8. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V. Uric acid and longterm outcomes in CKD. Am J Kidney Dis 2009; 53: 796-803.
9. Praticò D. Antioxidants and endothelium protection. Atherosclerosis 2005; 181: 215-224.
10. Ostenson CG. The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physio-logica Scandinavica 2001; 171: 241-247.
11. Koenig W, Meisinger C. Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? Clin Chem 2008; 54: 231-233.
12. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-252.
13. Loeffler LF, Navas-Acien A, Brady TM, Miller ER 3rd, Fadrowski JJ. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006. Hypertension 2012; 59: 811-817.
14. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
15. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
16. Maruhashi T, Nakashima A, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Goto C, Noma K, Tomiyama H, Takase B, Yamashina A, Higashi Y. Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ Open 2013; 3: e003659.
17. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sánchez-Lozada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, Acosta JH. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005; 16: 1909-1919.
18. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
19. Erdogan D, Gullu H, Calıskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H. Rela-tionship of serum uric acid to measures of endothelial function and atherosclerosis in heal-thy adults. Int J Clin Pract 2005; 59: 1276-1282.
20. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolik syndrome in woman and men. Metabolism 2008; 57: 845-852.
21. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: 625-631.
22. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005; 96: 1576-1578.
23. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
24. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006; 55: 3127-3132.
25. Matheus AS, Tibirica E, da Silva PB, de Fatima Bevilacqua da Matta M, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med 2011; 28: 1188-1193.
26. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004; 90: 155-159.
27. Doehner W, Schone N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo controlled studies. Circulation 2002; 105: 2619-2624.
28. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888-2897.
29. Bayram D, Tuğrul Sezer M, İnal S, Altuntaş A, Kıdır V, Orhan H. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients. Clin Exp Nephrol 2015; 19: 443-449.
30. Melendez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N. Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res 2012; 37: 1-6.
31. Garber AJ. Vascular disease and lipids in diabetes. Med Clin North Am 1998; 82: 931-948.
32. Laedia AM, Ladeia-Frota C, Pinho L, Stefanelli E, Adan L. Endothelial dysfunction is correlated with microalbuminuria in children with short-duration type 1 diabetes. Diabetes Care 2005; 28: 2048-2050.
33. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
34. Steuhower CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. Kidney Int Suppl 2004; 92: 42-44.
35. Lee Je, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962-967.
36. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68: 796-801.
37. Toda N, Arakawa K. Salt-induced hemodynamic regulation mediated by nitric oxide. J Hypertens 2011; 29: 415-424.
38. Sundstrom J, Sullıvan L, D’agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28-33.